These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38395848)

  • 1. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome.
    Avrahamy H; Pollak Y; Shriki-Tal L; Genstil L; Hirsch HJ; Gross-Tsur V; Benarroch F
    Compr Psychiatry; 2015 Apr; 58():189-97. PubMed ID: 25677112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium.
    Schwartz L; Caixàs A; Dimitropoulos A; Dykens E; Duis J; Einfeld S; Gallagher L; Holland A; Rice L; Roof E; Salehi P; Strong T; Taylor B; Woodcock K
    J Neurodev Disord; 2021 Jun; 13(1):25. PubMed ID: 34148559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
    Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
    J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Bittel D; Butler MG
    J Child Psychol Psychiatry; 2011 May; 52(5):580-7. PubMed ID: 21418060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trials in Prader-Willi Syndrome: A Review.
    Mahmoud R; Kimonis V; Butler MG
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
    Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
    Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of hyperphagia in Prader-Willi syndrome.
    Dykens EM; Maxwell MA; Pantino E; Kossler R; Roof E
    Obesity (Silver Spring); 2007 Jul; 15(7):1816-26. PubMed ID: 17636101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome.
    Rice LJ; Lagopoulos J; Brammer M; Einfeld SL
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1041-1048. PubMed ID: 27338833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
    Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
    Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
    Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
    Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.
    Roof E; Deal CL; McCandless SE; Cowan RL; Miller JL; Hamilton JK; Roeder ER; McCormack SE; Roshan Lal TR; Abdul-Latif HD; Haqq AM; Obrynba KS; Torchen LC; Vidmar AP; Viskochil DH; Chanoine JP; Lam CKL; Pierce MJ; Williams LL; Bird LM; Butler MG; Jensen DE; Myers SE; Oatman OJ; Baskaran C; Chalmers LJ; Fu C; Alos N; McLean SD; Shah A; Whitman BY; Blumenstein BA; Leonard SF; Ernest JP; Cormier JW; Cotter SP; Ryman DC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1696-1708. PubMed ID: 36633570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetylcysteine provides limited efficacy as treatment option for skin picking in Prader-Willi syndrome.
    Wieting J; Deest M; Bleich S; Frieling H; Eberlein C
    Am J Med Genet A; 2022 Mar; 188(3):828-835. PubMed ID: 34854203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.
    Kayadjanian N; Vrana-Diaz C; Bohonowych J; Strong TV; Morin J; Potvin D; Schwartz L
    PLoS One; 2021; 16(3):e0248739. PubMed ID: 33765021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.
    Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP
    J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressive and receptive language in Prader-Willi syndrome: report on genetic subtype differences.
    Dimitropoulos A; Ferranti A; Lemler M
    J Commun Disord; 2013; 46(2):193-201. PubMed ID: 23295077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of executive function abilities in adults with Prader-Willi syndrome.
    Walley RM; Donaldson MD
    J Intellect Disabil Res; 2005 Aug; 49(Pt 8):613-25. PubMed ID: 16011554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
    Wevrick R
    Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.